4.4 (0.83%)
4.4 (0.83%) 12.56 pm | 18 May 2012 | Source: CNBC-TV18
Lupin’s CFO S Ramesh tells CNBC-TV18 that he anticipates strong growth in FY13-14 from US....
5.48 pm | 10 May 2012 | Source: CNBC-TV18
Higher tax expenses led to a decline in consolidated net profit of pharma company, Lupin in the fourth quarter of FY12. The company posted a decline o...